US 7884199
HCV NS3-NS4 protease resistance mutants
granted A61KA61K38/162A61P
Quick answer
US patent 7884199 (HCV NS3-NS4 protease resistance mutants) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K38/162, A61P, A61P1/16, A61P31/12